This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy International Europe
1-3 December 2025
Mercure Hotel MOABerlin, Germany
Book Now
Menu
Book
Key Sessions
Frederik Buysse
Keynote: Building a CAR-T Manufacturing Facility from a Greenfield to Operation
Legend Biotech
Hiroyuki Usuda
Panel Discussion: Strategies for Scaling Up, Accelerating and Commercialising Gene Therapy Manufacturing
Astellas Pharma Europe Ltd
keyboard_arrow_right

Monday 1st December – Day 1 Main Conference - GMT (Greenwich Mean Time, GMTZ)

keyboard_arrow_leftSearch & Filter
search
Monday 1st December – Day 1 Main Conference - GMT (Greenwich Mean Time, GMTZ)
search
Showing 1 of 1 Streams
11:10 - 11:15
Chairperson's Opening Remarks
  • Hiroyuki Usuda - Scouting & Transaction Lead, Business Development, Astellas Pharma Europe Ltd
11:15 - 11:45
Toward Profitable Implementation of Low Cost AAV Viral Vectors: Engineered HEK-293 Cells and New Manufacturing Tools Will Combine to Yield High-Productivity Producer Cells
  • Larry Forman - Founder and CEO, CHO Plus, Inc.
11:45 - 12:15
Manufacturing Scale Upstream Process Evolution: From External Development to Internal Facility Establishment
  • Giovanni Ganendra - Upstream Process Science Senior Scientist, UCB
12:15 - 12:45
Master the Upstream: Using Innovation and Know-How to Drive Gene Therapy Forward
  • Clément Pèbre - Field Application Scientist, Cytiva
Showing 1 of 1 Streams
14:00 - 14:30
Full Capsids Enrichment Polishing Benchmark
  • Julie Aubert - DSP Development Engineer, Généthon
14:30 - 15:00
Applying Viral Vector Vaccine Learnings to Gene Therapy: To Expect the Unexpected
  • Mirjana Cvijanovic - Scientific Sr. Manager, Johnson & Johnson
15:00 - 15:30
Orthogonal PAT Analytics - Essential to Enable Robust Production of Viral Vectors and LNPs
  • Aleš Štrancar - Managing Director, Sartorius BIA Separations
Showing 1 of 1 Streams
16:10 - 16:40
The Need for an Unbiased Assay to Detect and Quantify Replication Competent AAV in Clinical Vector Products
  • Fabien Dorange - Director Analytical Sciences, SparingVision
16:40 - 17:10
Panel Discussion: Strategies for Scaling Up, Accelerating and Commercialising Gene Therapy Manufacturing
  • Hiroyuki Usuda - Scouting & Transaction Lead, Business Development, Astellas Pharma Europe Ltd
  • Markus Haindl - Global Head Gene Therapy Technical Research & Development, Roche-Genentech
NextTuesday 2nd December – Day 2 Main Conference
Filter
Streams
Clear
Topics
Choose Day